Vyprodáno
Parametry
- 168 stránek
- 6 hodin čtení
Více o knize
With a minimum of side effects, low toxicity in overdose and a broad range of clinical applications, selective serotonin re-uptake inhibitors have found widespread and increasing use in psychiatry worldwide. Here is the most comprehensive reference source available on these important drugs. Beginning with examinations of the drugs' pharmacology their effects on serotonergic function and the central role of serotonin in many psychiatric disorders, the book moves on to reviews of clinical trials in many psychiatric conditions. Finally, an important chapter discusses clinical issues in the use of these agents.
Nákup knihy
Perspectives in Psychiatry - 1: Selective Serotonin Re-Uptake Inhibitors, John Preston Feighner, W. F. Boyer
- Jazyk
- Rok vydání
- 1991
- product-detail.submit-box.info.binding
- (pevná)
Jakmile se objeví, pošleme e-mail.
Doručení
Platební metody
Nikdo zatím neohodnotil.
- Titul
- Perspectives in Psychiatry - 1: Selective Serotonin Re-Uptake Inhibitors
- Podtitul
- The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline
- Jazyk
- anglicky
- Autoři
- John Preston Feighner, W. F. Boyer
- Vydavatel
- Wiley
- Rok vydání
- 1991
- Vazba
- pevná
- Počet stran
- 168
- ISBN10
- 0471928909
- ISBN13
- 9780471928904
- Série
- Štítky
- Naučná literatura, Společenské vědy, Zdraví & Lékařství, Psychologie, Duševní zdraví, Psychiatrie, Farmakologie
- Anotace
- With a minimum of side effects, low toxicity in overdose and a broad range of clinical applications, selective serotonin re-uptake inhibitors have found widespread and increasing use in psychiatry worldwide. Here is the most comprehensive reference source available on these important drugs. Beginning with examinations of the drugs' pharmacology their effects on serotonergic function and the central role of serotonin in many psychiatric disorders, the book moves on to reviews of clinical trials in many psychiatric conditions. Finally, an important chapter discusses clinical issues in the use of these agents.